WANBURY
Back to Income Statement
|
WANBURY Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹-10 Cr | ₹81 Cr | ₹-13 Cr | ₹64 Cr | ₹-25 Cr |
What is the latest Consolidated Net Profit of WANBURY ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹-10 Cr |
Mar2023 | ₹81 Cr |
Mar2022 | ₹-13 Cr |
Mar2021 | ₹64 Cr |
Mar2020 | ₹-25 Cr |
How is Consolidated Net Profit of WANBURY Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹-10 Cr | Negative | |
Mar2023 | ₹81 Cr | Positive | |
Mar2022 | ₹-13 Cr | Negative | |
Mar2021 | ₹64 Cr | Positive | |
Mar2020 | ₹-25 Cr | - |
Compare Consolidated Net Profit of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹786.9 Cr | -12.9% | -25.5% | 91.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹428,533.0 Cr | -3.3% | -1.6% | 39.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹153,076.0 Cr | -2.1% | -2.8% | 48.1% | Stock Analytics | |
CIPLA | ₹118,723.0 Cr | -1.4% | 1.1% | 17.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,998.0 Cr | 0.3% | 9.4% | 19.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,031.0 Cr | 4.4% | 1.8% | 42% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -12.9% |
-25.5% |
91.1% |
SENSEX | -2.3% |
-5.1% |
7.4% |
You may also like the below Video Courses